1. Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy. (October 2018) Authors: Stolte, Benjamin; Totzeck, Andreas; Kizina, Kathrin; Bolz, Saskia; Pietruck, Lena; Mönninghoff, Christoph; Guberina, Nika; Oldenburg, Denise; Forsting, Michael; Kleinschnitz, Christoph; Hagenacker, Tim Journal: Therapeutic advances in neurological disorders Issue: Volume 11(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM study. (August 2021) Authors: Totzeck, Andreas; Ramakrishnan, Elakiya; Schlag, Melina; Stolte, Benjamin; Kizina, Kathrin; Bolz, Saskia; Thimm, Andreas; Stettner, Mark; Marchesi, Julian R.; Buer, Jan; Kleinschnitz, Christoph; Verhasselt, Hedda Luise; Hagenacker, Tim Journal: Therapeutic advances in neurological disorders Issue: Volume 14(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study. Issue 4 (April 2020) Authors: Hagenacker, Tim; Wurster, Claudia D; Günther, René; Schreiber-Katz, Olivia; Osmanovic, Alma; Petri, Susanne; Weiler, Markus; Ziegler, Andreas; Kuttler, Josua; Koch, Jan C; Schneider, Ilka; Wunderlich, Gilbert; Schloss, Natalie; Lehmann, Helmar C; Cordts, Isabell; Deschauer, Marcus; Lingor, Paul; ... Journal: Lancet neurology Issue: Volume 19:Issue 4(2020) Page Start: 317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Observational cohort study of neurological involvement among patients with SARS-CoV-2 infection. (February 2021) Authors: Fleischer, Michael; Köhrmann, Martin; Dolff, Sebastian; Szepanowski, Fabian; Schmidt, Karsten; Herbstreit, Frank; Güngör, Cansu; Stolte, Benjamin; Steiner, Katharina Marie; Stadtler, Christine; Riße, Joachim; Fiedler, Melanie; Meyer zu Hörste, Gerd; Mausberg, Anne-K.; Kill, Clemens; Forsting, Mic... Journal: Therapeutic advances in neurological disorders Issue: Volume 14(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Reply to: Minimal detectable change and minimal clinically important differences in spinal muscular atrophy patients. (21st March 2021) Authors: Stolte, Benjamin; Kleinschnitz, Christoph; Hagenacker, Tim Journal: European journal of neurology Issue: Volume 28:Number 6(2021) Page Start: e42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study. Issue 5 (May 2023) Authors: Bril, Vera; Drużdż, Artur; Grosskreutz, Julian; Habib, Ali A; Mantegazza, Renato; Sacconi, Sabrina; Utsugisawa, Kimiaki; Vissing, John; Vu, Tuan; Boehnlein, Marion; Bozorg, Ali; Gayfieva, Maryam; Greve, Bernhard; Woltering, Franz; Kaminski, Henry J; Genge, Angela; Massie, Rami; Berube, Maxime; Br... Journal: Lancet neurology Issue: Volume 22:Issue 5(2023) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study. Issue 5 (May 2023) Authors: Howard, James F; Bresch, Saskia; Genge, Angela; Hewamadduma, Channa; Hinton, John; Hussain, Yessar; Juntas-Morales, Raul; Kaminski, Henry J; Maniaol, Angelina; Mantegazza, Renato; Masuda, Masayuki; Sivakumar, Kumaraswamy; Śmiłowski, Marek; Utsugisawa, Kimiaki; Vu, Tuan; Weiss, Michael D; Zajda, M... Journal: Lancet neurology Issue: Volume 22:Issue 5(2023) Page Start: 395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatment. Issue 5 (31st March 2021) Authors: Freigang, Maren; Wurster, Claudia D.; Hagenacker, Tim; Stolte, Benjamin; Weiler, Markus; Kamm, Christoph; Schreiber‐Katz, Olivia; Osmanovic, Alma; Petri, Susanne; Kowski, Alexander; Meyer, Thomas; Koch, Jan C.; Cordts, Isabell; Deschauer, Marcus; Lingor, Paul; Aust, Elisa; Petzold, Daniel; Ludolp... Journal: Annals of clinical and translational neurology Issue: Volume 8:Issue 5(2021) Page Start: 1049 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen. (16th June 2021) Authors: Meyer, Thomas; Maier, André; Uzelac, Zeljko; Hagenacker, Tim; Günther, René; Schreiber‐Katz, Olivia; Weiler, Markus; Steinbach, Robert; Weyen, Ute; Koch, Jan Christoph; Kettemann, Dagmar; Norden, Jenny; Dorst, Johannes; Wurster, Claudia; Ludolph, Albert C.; Stolte, Benjamin; Freigang, Maren; Osma... Journal: European journal of neurology Issue: Volume 28:Number 8(2021) Page Start: 2582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy. (March 2021) Authors: Osmanovic, Alma; Ranxha, Gresa; Kumpe, Mareike; Wurster, Claudia D.; Stolte, Benjamin; Cordts, Isabell; Günther, René; Freigang, Maren; Müschen, Lars H.; Binz, Camilla; Hermann, Andreas; Deschauer, Marcus; Lingor, Paul; Ludolph, Albert C.; Hagenacker, Tim; Schreiber-Katz, Olivia; Petri, Susanne Journal: Therapeutic advances in neurological disorders Issue: Volume 14(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗